Trust CO Of Kansas Amgen Inc Transaction History

Trust CO Of Kansas

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $484,491 - $539,154	-2,100 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $11,679 - $12,957	-50 Reduced 2.33%	2,100 $512,000
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $31,733 - $36,979	143 Added 7.13%	2,150 $535,000
Q4 2020 Feb 17, 2021	SELL	$216.38 - $257.67 $8,006 - $9,533	-37 Reduced 1.81%	2,007 $461,000
Q3 2020 Dec 18, 2020	SELL	$234.65 - $260.95 $21,822 - $24,268	-93 Reduced 4.35%	2,044 $520,000

Q2 2020 Aug 17, 2020	SELL	$197.81 - $242.74 $668,597 - $820,461	-3,380 Reduced 61.27%	2,137 $504,000
Q4 2019 Feb 20, 2020	BUY	$189.21 - $243.2 $1.04 Million - $1.34 Million	5,517 New	5,517 $1.33 Million

2,933

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Trust CO Of Kansas, based on Form 13F filings with the SEC.

Stay updated on Trust CO Of Kansas with notifications on news.